Literature DB >> 28447414

Review of D-dimer testing: Good, Bad, and Ugly.

L-A Linkins1,2, S Takach Lapner1,2.   

Abstract

D-dimer assays are commonly used in clinical practice to exclude a diagnosis of deep vein thrombosis or pulmonary embolism. More recently, they have been also been used to guide patients with unprovoked venous thromboembolism (VTE) when faced with the decision to continue or stop anticoagulation after initial treatment is complete. D-dimer assays vary widely with respect to the antibody used, method of capture, instrumentation required, and calibration standard. These differences have an important influence on the operating characteristics of the assays. Consequently, the evidence available in the literature for one assay cannot simply be extrapolated to another. In this review, we will outline the general properties of D-dimer assays, discuss the concept of raising the D-dimer threshold used in diagnosis of VTE according to pretest probability and age, and provide clinical perspective on the role of D-dimer testing in the diagnosis and prognosis of VTE.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  D-dimer; DVT; PE; diagnosis; prognosis; venous thromboembolism

Mesh:

Substances:

Year:  2017        PMID: 28447414     DOI: 10.1111/ijlh.12665

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  45 in total

1.  What makes D-dimer assays suspicious-heterophilic antibodies?

Authors:  Ying Wu; Ying-Xiu Xiao; Teng-Yi Huang; Xian-Yan Zhang; Huan-Bing Zhou; Xue-Xuan Zhang; Ying-E Wu
Journal:  J Clin Lab Anal       Date:  2018-10-15       Impact factor: 2.352

Review 2.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

3.  D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.

Authors:  Vaibhav Kumar; Joseph R Shaw; Nigel S Key; Anton Ilich; Ranjeeta Mallick; Philip S Wells; Marc Carrier
Journal:  Oncologist       Date:  2020-10-12

Review 4.  State-of-the-Art Imaging for the Evaluation of Pulmonary Embolism.

Authors:  Leonid Roshkovan; Harold Litt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

Review 5.  Pulmonary Embolism for the Cardiologist: Emphasis on Diagnosis.

Authors:  Jonathan Halevy; Mary Cushman
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

6.  Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis.

Authors:  Sally Bevan; Colin Longstaff
Journal:  J Thromb Haemost       Date:  2021-11-24       Impact factor: 16.036

7.  Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation.

Authors:  Gabriela Athziri Sánchez-Zuno; Guillermo González-Estevez; Mónica Guadalupe Matuz-Flores; Gabriela Macedo-Ojeda; Jorge Hernández-Bello; Jesús Carlos Mora-Mora; Edsaúl Emilio Pérez-Guerrero; Mariel García-Chagollán; Natali Vega-Magaña; Francisco Javier Turrubiates-Hernández; Andrea Carolina Machado-Sulbaran; José Francisco Muñoz-Valle
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

Review 8.  Tranexamic acid evidence and controversies: An illustrated review.

Authors:  Nicole Relke; Nicholas L J Chornenki; Michelle Sholzberg
Journal:  Res Pract Thromb Haemost       Date:  2021-07-14

9.  The clinical significance of ultra-high D-dimer levels.

Authors:  Kristin Schafer; Eric Goldschmidt; Drew Oostra; John Fish; Todd Russell; Fedor Lurie
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2021-06-23

10.  Diagnostic Value of Neutrophil Lymphocyte Ratio and D-Dimer as Biological Markers of Deep Vein Thrombosis in Patients Presenting with Unilateral Limb Edema.

Authors:  Ikhwan Rinaldi; Rachmat Hamonangan; Mohamad Syahrir Azizi; Rahmat Cahyanur; Fadila Wirawan; Atikah Isna Fatya; Ageng Budiananti; Kevin Winston
Journal:  J Blood Med       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.